Guest guest Posted November 17, 2001 Report Share Posted November 17, 2001 Harvard Health Publicationshttp://www.health.harvard.edu/medline/Women/W801a.html Harvard Women's Health Watch August 2001 What We Still Don't Know About Soy In Asia, soy foods have been a dietary staple for centuries. In the United States, health guru and breakfast food entrepreneur John Harvey Kellogg introduced soybean products in the 1920s as healthful substitutes for milk and meat. Yet for decades most Americans thought of soy primarily as an unappealing health food store staple or as a mystery meat extender served in cafeterias and mess halls. Over the last several years, however, American attitudes toward soy have shifted from dubious to near-devotional. Now supermarket shelves are graced by thousands of soy products - everything from snack foods and breakfast cereals to cheese and coffee substitutes. It's estimated that we will spend more than $3 billion this year on soy foods, not counting supplements made from concentrated soy compounds. What happened? To a large extent, we became convinced that soy equals healthy. Soybeans are unique among plant foods in supplying all the essential amino acids that the human body needs, making soy protein similar in quality to meat protein -- but with largely unsaturated instead of saturated fat. In addition, soy contains the isoflavones genistein and daidzein, plant hormones that seem able to either mimic or counter the effects of estrogen. They have been proposed as helpful in preventing several hormone-related diseases. Soy's biggest official boost came with endorsements from the Food and Drug Administration (FDA), in 1999, and the American Heart Association (AHA), last year, for its ability to lower cholesterol. That spurred the recent boom in soy marketing. But it also worries some experts who believe that our rush to consume large amounts of soy - and, in particular, to take supplements with large amounts of soy isoflavones - is premature, given the current evidence on soy's health benefits and possible risks. ..Potential Problems Brain cells. In the 1960s, researchers took dietary information from about 8,000 men of Japanese descent participating in the Honolulu Heart Study. In tests administered three decades later, when the men were ages 71-93, those who had eaten the most tofu (more than two servings a week) performed less well on cognitive tests. The researchers also tested their wives and found a similar decline in cognitive function among those women who ate the most tofu. Among men for whom the researchers had brain imaging or autopsy results, greater tofu consumption was associated with more brain atrophy. The brains of men who ate a lot of tofu generally resembled those of men about five years older who had eaten little tofu. Reproductive tract. Because of the hormonal effects of soy isoflavones (which have been found in human amniotic fluid), some scientists worry that large amounts of soy may cause deleterious changes in the reproductive tract, particularly during early life. Indeed, animal studies suggest that exposure to genistein before and just after birth may affect ovarian follicle development. In May, the National Toxicology Program called for further study of the health effects of genistein because of credible evidence that hormone-like chemicals can produce changes in the female reproductive tract and the prostate gland. The National Institutes of Health is also sponsoring an infancy-to-adulthood study to detect possible adverse effects of consuming soy-based formulas in infancy. Thyroid. Some physicians have reported cases in which women developed goiter or symptoms of hypothyroidism while consuming large amounts of soy. In the laboratory, genistein interferes with a key enzyme in the thyroid gland, thyroxine peroxidase, making some scientists concerned about the impact of soy on thyroid function. But researchers tracking hormone levels in premenopausal and postmenopausal women taking soy isoflavones have found no clinically significant changes in thyroid function. As a precaution, if you are being evaluated for a thyroid problem or are receiving thyroid medication, tell your endocrinologist about your use of soy foods and supplements. If you are taking thyroid hormone to correct hypothyroidism, soy may interfere with the absorption of the medication in your intestines. To minimize this impact (thereby allowing you to take the lowest possible dose), your endocrinologist may advise you not to take your thyroid medication within 2-3 hours of a meal that contains soy. In infants who require thyroid hormone because of congenital hypothyroidism, soy formula can cause a significant absorption problem and should not be consumed. Allergies. Soy is one of the eight food groups most often responsible for allergic reactions. It's difficult to avoid soy entirely, since it turns up in small amounts in many products, such as water-packed tuna, that are not themselves soy foods. In May, a group of major food manufacturers agreed to label products containing even tiny amounts of soy and other common allergens. Evidence on Benefits Lowering cholesterol. Soy's impact on the risk for heart attack and stroke has not been directly evaluated. However, last November, the AHA recommended that people include soy protein foods as part of a low-fat, low-cholesterol diet in order to promote heart health. The AHA's Nutrition Committee acted after reviewing evidence from a 1995 meta-analysis of 38 controlled clinical trials, along with several newer studies assessing soy's impact on lipid levels. It concluded that consuming 25-50 grams of soy protein daily could reduce LDL cholesterol by 4%-8%. People with normal cholesterol levels show slight improvement, and benefits are proportionately greater with moderately high cholesterol levels. But the impact of dietary soy is decidedly modest - roughly equivalent to the effect of adding soluble fiber (for example, from oat bran or pectin) to your diet. In the human studies reviewed by the AHA, soy protein that contained isoflavones lowered cholesterol significantly more than soy protein without isoflavones. And isoflavones separated from soy protein did not lower cholesterol. It may be that the cholesterol-lowering effect of soy products is due to a synergy among soy protein, isoflavones, and other components of soy. Easing menopausal symptoms. Because soy isoflavones have certain estrogenic effects, women and researchers have looked to soy as a possible alternative to standard hormone replacement therapy. Greater intake of dietary soy has been proposed to explain why Japanese women report fewer hot flashes than American women. Within Japan, researchers found that women with the highest consumption of soy products and the highest intake of isoflavones had fewer hot flashes than those who ate little soy. But when soy is given to Western women in controlled studies to prevent hot flashes, the benefits have been slight. For example, in a trial of postmenopausal women in Italy, those taking soy protein reported 45% fewer moderate or severe hot flashes after 12 weeks of treatment, but women taking a non-soy protein powder also improved, by 30%. In comparison, hormone replacement therapy has been shown to reduce hot flashes by at least 70%. Protecting bone. Two prospective studies have found some evidence that soy consumption might help prevent the bone loss associated with menopause. In one, perimenopausal women still having regular periods but experiencing 10 or more hot flashes a week were assigned to groups receiving supplements, variously, of isoflavone-rich soy, isoflavone-poor soy, or a whey protein control. After six months, women receiving whey had significant losses in bone mass and density. Those receiving isoflavone-poor soy had non-significant bone loss, while those receiving isoflavone-rich soy showed a small improvement. In another six-month study, postmenopausal women showed an increase in bone mineral content and density in their lumbar spine (but not in the thigh) after taking an isoflavone-rich soy preparation. Milk protein and soy protein with a low concentration of isoflavones gave no protection. If the level of protection documented in these studies continued for many years, women taking isoflavone-containing soy products might be at lower risk for osteoporosis. However, the researchers caution that six months is a relatively short period of time in terms of bone turnover. Longer-term trials are underway. Soy and Breast Cancer: Promise or Peril? Asian nations with high soy consumption have lower rates of breast cancer, which suggests that components in soy may somehow protect breast tissue. But population-based differences are far from proof of a cause-and-effect relationship. Many other features of a particular culture, including other dietary components, could account for such patterns. Studies undertaken in China and Japan have not identified any consistent relationship between soy intake and breast cancer risk. For now, it's unclear whether adding soy to the diet might reduce a woman's risk of developing breast cancer, and there's no evidence that soy is of any particular benefit for women who already have breast cancer. Still, there are reasons for the research interest in this connection. Soy isoflavones resemble tamoxifen and raloxifene, selective estrogen receptor modulators already used for breast cancer prevention. Like these medications, isoflavones attach to estrogen receptors but act differently from estrogen in some tissues. In addition to hormonal influences, isoflavones also have anti-tumor activity and block the formation of blood vessels in chemically induced breast tumors in animals. Researchers are investigating the possibility that they may act against non-hormonal cancers as well as the hormonally influenced cancers of the breast and prostate. Soy's effects on breast tissue are not well understood. Its impact on breast cancer may depend on when in a woman's life she consumes it. There is the possibility, bolstered by some animal studies, that soy must be consumed early in life to exert a protective effect on breast tissue. Animal studies also suggest that prepubertal exposure to the soy component genistein is protective. And when premenopausal women drink isoflavone-containing soymilk, it significantly lowers their circulating levels of both estrogen and progesterone, potentially protecting them from estrogen's cell-stimulating effects. On the other hand, one small, randomized study found that soy consumption (in the form of textured vegetable protein) was associated with increased breast tissue proliferation in a group of premenopausal women with benign or malignant breast disease. In postmenopausal women with little estrogen production, isoflavones with even a weak estrogen-like effect may potentially stimulate the growth of estrogen-dependent breast tumors. Women receiving tamoxifen as treatment for breast cancer often wonder whether it would be valuable or safe to add soy foods or supplements to their daily regimen. Unfortunately, no definitive studies are available, according to researchers at Harvard Medical School. Some experts caution that anything with desirable estrogenic effects can also have unwanted estrogenic effects, e.g., increased cell reproduction. This may be especially true of concentrated soy supplements. Others researchers believe that breast cancer patients are probably fine if they follow an Asian diet and lifestyle in which soy foods are substituted for some meat protein, and lots of vegetables and exercise are included. Certainly before starting isoflavone supplements or changing your diet to incorporate large amounts of soy, you should discuss it with your oncologist Web related inquiries: jan_phillips ©2000 President and Fellows of Harvard College Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.